SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-020785
Filing Date
2017-11-01
Accepted
2017-11-01 16:10:21
Documents
3
Period of Report
2017-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20171101.htm 8-K 50649
2 EX-99.1 life-ex991_87.htm EX-99.1 18494
3 GRAPHIC g2017110118322063514358.jpg GRAPHIC 17344
  Complete submission text file 0001564590-17-020785.txt   94469
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 171169051
SIC: 2836 Biological Products, (No Diagnostic Substances)